STOCK TITAN

Applied Dna Scie Stock Price, News & Analysis

APDN NASDAQ

Company Description

Overview

Applied DNA Sciences is a biotechnology company specializing in the enzymatic production and detection of synthetic deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) using advanced polymerase chain reaction (PCR) technologies. The company caters to multiple industries with a focus on nucleic acid-based therapeutics, molecular diagnostics, and forensic authentication to secure supply chains and protect intellectual property.

Core Business Segments

  • Therapeutic DNA Production Services: Leveraging its proprietary Linea DNA platform, the company produces highly pure, scalable synthetic DNA that serves as a critical component in the manufacture of nucleic acid-based therapies, including mRNA therapeutics and DNA vaccines.
  • MDx Testing Services: Through its molecular diagnostics (MDx) capabilities, Applied DNA Sciences performs advanced genetic and clinical laboratory testing. These services are directed at ensuring accurate diagnostic results and personalized treatment strategies, contributing to better patient outcomes.
  • DNA Tagging and Security Products & Services: With innovative solutions like the CertainT platform, the company provides botanical-DNA based security and authentication technology. This system verifies the authenticity of materials in supply chains, thereby protecting brands, assets, and intellectual property from fraud, counterfeiting, and diversion.

Key Technologies and Platforms

Applied DNA Sciences stands out due to its integration of state-of-the-art biochemical processes and robust forensic methodologies. Its proprietary platforms include:

  • Linea DNA: A cell-free, enzymatic production platform that generates high-fidelity synthetic DNA constructs with versatile applications in therapeutics and diagnostics.
  • Linea IVT: This innovative platform pairs DNA IVT templates with a next-generation RNA polymerase, streamlining mRNA production while reducing double-stranded RNA contamination, a critical factor in ensuring product purity and regulatory compliance.
  • CertainT: A comprehensive traceability solution that integrates isotopic testing, DNA tagging, and genomic analyses. This platform delivers multiple key proof points to verify the origin and authenticity of raw materials and finished products, particularly within the textile industry.

Market Position and Strategic Significance

By combining advanced manufacturing protocols with forensic traceability techniques, Applied DNA Sciences provides robust solutions that address critical challenges across various sectors. The company's technologies not only enhance the efficiency of nucleic acid-based therapeutics production but also fortify supply chains against counterfeiting and fraud. Its unique approach of integrating multiple layers of verification underlines its commitment to quality, security, and innovation.

Operational Excellence and Industry Impact

The firm's reliance on enzymatic PCR-based processes sets it apart as an expert in producing synthetic DNA with high scalability and fidelity. This technical proficiency supports a diverse customer base, including pharmaceutical developers, diagnostic laboratories, governmental agencies, and global manufacturers who demand reliable, secure, and innovative solutions. Furthermore, by continuously refining its production and testing methodologies, the company demonstrates a strong dedication to research and development, ensuring its processes remain at the forefront of biotechnology innovation.

Conclusion

Overall, Applied DNA Sciences delivers comprehensive solutions that span from the production of synthetic DNA for advanced therapeutics to the forensic authentication of products in global supply chains. Its balanced focus on clinical, industrial, and security applications positions the company as a multifaceted player in the biotechnology sector, dedicated to enhancing product integrity and operational efficiency through innovative, proof-based technologies.

Stock Performance

$3.56
-31.93%
1.67
Last updated: September 30, 2025 at 11:40
-99.46 %
Performance 1 year

Financial Highlights

$1,196,617
Revenue (TTM)
-$2,668,713
Net Income (TTM)
-$3,326,074
Operating Cash Flow

Upcoming Events

OCT
01
October 1, 2025 - December 31, 2025 Product

LineaPCR™ launch

Planned launch of LineaPCR™ in Q4 FY2025
OCT
01
October 1, 2025 Financial

Private placement close

Closing of up to $58M private placement financing
JAN
01
January 1, 2026 - March 31, 2026 Operations

LineaDNA shipments start

First quarterly LineaDNA product delivery under supply agreement

Short Interest History

Last 12 Months
Loading short interest data...

Days to Cover History

Last 12 Months
Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Applied Dna Scie (APDN)?

The current stock price of Applied Dna Scie (APDN) is $5.23 as of September 29, 2025.

What is the market cap of Applied Dna Scie (APDN)?

The market cap of Applied Dna Scie (APDN) is approximately 5.3M. Learn more about what market capitalization means .

What is the revenue (TTM) of Applied Dna Scie (APDN) stock?

The trailing twelve months (TTM) revenue of Applied Dna Scie (APDN) is $1,196,617.

What is the net income of Applied Dna Scie (APDN)?

The trailing twelve months (TTM) net income of Applied Dna Scie (APDN) is -$2,668,713.

What is the earnings per share (EPS) of Applied Dna Scie (APDN)?

The diluted earnings per share (EPS) of Applied Dna Scie (APDN) is -$0.56 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Applied Dna Scie (APDN)?

The operating cash flow of Applied Dna Scie (APDN) is -$3,326,074. Learn about cash flow.

What is the profit margin of Applied Dna Scie (APDN)?

The net profit margin of Applied Dna Scie (APDN) is -223.02%. Learn about profit margins.

What is the operating margin of Applied Dna Scie (APDN)?

The operating profit margin of Applied Dna Scie (APDN) is -247.70%. Learn about operating margins.

What is the gross margin of Applied Dna Scie (APDN)?

The gross profit margin of Applied Dna Scie (APDN) is 57.17%. Learn about gross margins.

What is the current ratio of Applied Dna Scie (APDN)?

The current ratio of Applied Dna Scie (APDN) is 4.72, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of Applied Dna Scie (APDN)?

The gross profit of Applied Dna Scie (APDN) is $684,107 on a trailing twelve months (TTM) basis.

What is the operating income of Applied Dna Scie (APDN)?

The operating income of Applied Dna Scie (APDN) is -$2,964,001. Learn about operating income.

What is the core business of Applied DNA Sciences?

Applied DNA Sciences is focused on the enzymatic production and detection of synthetic DNA and RNA. Its offerings span nucleic acid-based therapeutics, molecular diagnostics, and forensic supply chain security solutions.

How does the company ensure supply chain security?

The company utilizes its proprietary CertainT platform, which combines DNA tagging with isotopic and genomic testing to authenticate materials. This multi-proof approach helps verify origin and protect brands against counterfeiting and diversion.

What are the primary business segments of Applied DNA Sciences?

The company operates across three main segments: therapeutic DNA production services, MDx testing services in molecular diagnostics, and DNA tagging/security products for supply chain authentication.

What technologies support their manufacturing processes?

Applied DNA employs advanced PCR-based enzymatic processes. Its proprietary platforms, such as Linea DNA and Linea IVT, facilitate scalable and high-fidelity production of synthetic DNA and mRNA.

How does the Linea IVT platform enhance mRNA production?

The Linea IVT platform combines DNA IVT templates with a proprietary RNA polymerase, significantly reducing double-stranded RNA contamination and streamlining the mRNA manufacturing workflow.

Who are the typical customers of Applied DNA Sciences?

The company's customers include pharmaceutical and biotechnology firms, diagnostic laboratories, governmental agencies, and industrial manufacturers that require secure, high-quality nucleic acid solutions.

How does Applied DNA Sciences maintain quality and product integrity?

Through rigorous process development and the use of state-of-the-art enzymatic production technologies, the company ensures high fidelity and consistency in its synthetic DNA products, while forensic traceability measures further authenticate its outputs.

In what ways does Applied DNA contribute to innovation in biotechnology?

By integrating advanced PCR technology with forensic authentication and scalable production platforms, the company provides innovative solutions that address both clinical and industrial challenges, fostering greater efficiency and security in genetic medicine and supply chain management.